Renaissance Technologies
CHTP

Renaissance Technologies’s CHELSEA THERAPEUTICS INT'L LTD CHTP Stock Holding History

Renaissance Technologies’s Portfolio CHTP Stock Details CHTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-33,306
Closed -$184K – 3171
2014
Q1 		$184K Sell
33,306
-683,188
-95% -$3.43M ﹤0.01% 2634
2013
Q4 		$3.18M Buy
716,494
+490,799
+217% +$1.66M 0.01% 1470
2013
Q3 		$675K Buy
225,695
+215,301
+2,071% +$618K ﹤0.01% 2188
2013
Q2 		$24K Buy
+10,394
New +$21K ﹤0.01% 2733

Other funds holding CHTP

Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Renaissance Technologies's CHTP Position: Q2 2014 in Review

Renaissance Technologies sold out of CHELSEA THERAPEUTICS INT'L LTD (CHTP) in Q2 2014, closing a stake of 33,306 shares — an estimated $184K sold.

Renaissance Technologies first reported a position in CHTP in Q2 2013 and held it in 4 quarters. The position peaked at $3.18M in Q4 2013. 6 funds tracked by Wall St. Rank hold CHTP as of Q2 2014.

  • Renaissance Technologies reported no remaining CHELSEA THERAPEUTICS INT'L LTD position as of Q2 2014 after selling out during the quarter.
  • Renaissance Technologies sold 33,306 CHELSEA THERAPEUTICS INT'L LTD shares in Q2 2014, an estimated $184K.
  • Renaissance Technologies first reported a position in CHELSEA THERAPEUTICS INT'L LTD in Q2 2013 and held it in 4 quarters.
  • Renaissance Technologies's CHELSEA THERAPEUTICS INT'L LTD position peaked at $3.18M in Q4 2013.
  • 6 funds tracked by Wall St. Rank held CHELSEA THERAPEUTICS INT'L LTD as of Q2 2014.

Based on Renaissance Technologies's 13F filing for Q2 2014, filed 13 Aug 2014.